『#47 - 600% in 3 Days: the execution playbook behind Abivax’s breakthrough in IBD』のカバーアート

#47 - 600% in 3 Days: the execution playbook behind Abivax’s breakthrough in IBD

#47 - 600% in 3 Days: the execution playbook behind Abivax’s breakthrough in IBD

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

“Within three days, we went from almost bankrupt… to one of the stars of the Nasdaq.”


In this conversation, I take you behind the scenes of a biotech journey that sounds almost unbelievable.


Marc de Garidel, CEO of Abivax, tells me how he rebuilt this French biotech from scratch, designed a strategy powerful enough to attract top US investors and executed one of the largest phase 3 programs in ulcerative colitis: a molecule from French public research (CNRS, Institut Curie and the University of Montpellier) which may have a major impact on patients.

This episode is a masterclass in leadership, execution, courage, and long-term thinking.


Here’s what you’ll hear about in this episode:

◾️ How Marc stepped into a company with almost no long-term plan… and why that turned out to be a surprising advantage.

◾️ The four pillars of a new strategy — and how one of them quietly set the stage for the breakthrough to come.

◾️ What it really takes to run a global phase 3 across dozens of countries — and why Abivax had to reinvent itself to pull it off.

◾️ A mechanism of action unlike anything else in IBD — and why this difference matters more than most people think.

◾️ The hidden lessons from a noisy phase 2 that helped transform the phase 3 into something no one saw coming.

◾️ A leadership philosophy built on transparency and speed, born from a single principle: in biotech, every day counts.

◾️ The unexpected market reaction that changed the fate of the company overnight — with numbers that almost don’t seem real.


If you want to hear a real behind-the-scenes story, hit play.


This episode is an exceptional inside look at what it truly takes to turn science into impact, stand your ground under pressure, and lead a biotech from survival… to breakthrough.



Find Marc de Garidel:
LinkedIn: https://www.linkedin.com/in/marc-de-garidel-097982/


Resources mentioned in the episode:

Abivax https://www.abivax.com/


Pharma Minds episodes mentioned:

His first interview in Pharma Minds in 2023: “CEO Marc De Garidel On Building Something Truly Impactful: Embrace Risks!” https://www.youtube.com/watch?v=mA3-OSltbwQ (in English)



🎧 New here? To get a quick overview of the episodes, download 25 Tips for Purposeful Leadership, a guide inspired by the best advice shared by my guests.


🤝 Want to connect or talk about your current challenges? Let’s connect on LinkedIn.


📩 Curious to dive deeper into the major shifts in the healthcare ecosystem? Subscribe to the Pharma Minds newsletter.


Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

まだレビューはありません